Mantle cell lymphoma in the Chinese: Clinicopathological features and treatment outcome

American Journal of Hematology

Volumn 59, Issue 4, 1998, Pages 295-301

  Chim, C S ^a   Chan, A C L ^a   Choo, C K ^a   Kwong, Y L ^a   Lie, A K W ^a   Liang, Raymond ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Immunophenotype; Mantle cell lymphoma; PCR; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DNA; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE SULFATE;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; HUMAN; IMMUNOPHENOTYPING; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HONG KONG; HUMANS; LYMPHOMA, INTERMEDIATE-GRADE; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, LOW-GRADE; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGAN SPECIFICITY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 0031785236     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199812)59:4<295::AID-AJH5>3.0.CO;2-N     Document Type: Article

References (35)

1. Lennert K, Stein H, Kaiserling E: Cytological and functional criteria for the classification of malignant lymphoma. Br J Cancer 31 (Suppl.): 29-43, 1975.
2. Weisenburger DD, Nathwani BN, Diamond LW, Winberg CD, Rappaport H: Malignant lymphoma of intermediate lymphocytic type. Cancer 48:1415-1425, 1981.
3. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Falini B; Gatter KC, Jaffe ES: Mantle cell lymphoma: A proposal for unification of morphologic. immunologic and molecular data. Am J Surg Pathol 16:637-640, 1992.
4. Weisenburger DD, Sanger WG, Amitage JO, Purtilo DT: Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 69:1617-1621, 1987.
5. de-Boer CJ, Loyson S, Kluin PM, Kluin-Nelemans HC, Schuring E, van-Krieken JH: Multiple breakpoints within the bcl-1 locus in B-cell lymphoma rearrangement of the cylin D1 gene. Cancer Res 53:4148-4152, 1993.
6. Rimokh R, Berger F, Delsol G, Charrin C, Bertheas MF, French M, Garoscio M, Felman P, Coiffier B, Bryon PA, Rochet M, Gentilhomme O, Germain D, Magaud JP: Rearrangement and overexpresssion of bcl-1/PRAD-1 gene in intermediate lymphocytic lymphoma and in t(11q13)-bearing leukemia. Blood 81:3063-3069, 1993.
7. William ME, Swerdlow SH, Meeker TC: Chromosome t(11,14) (q13;q32) breakpoints in centrocytic lymphoma are highly localised at the bcl-1 major translocation cluster. Leukemia 7:1437-1440, 1993.
8. Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud JP: Detection of the chromosomal translocation t(11,14) by polymerase chain reaction in mantle cell lymphoma. Blood 83:1871-1875, 1994.
9. Zucca E, Soldati G, Sehlegelberger B, Booth MJ, Weber-Matthiesen K, Cavalli F, Cotter FE: Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. Br J Haematol 89:665-670, 1995.
10. Williams ME, Nichols GE, Swerdlow SH, Stoler MH: In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma. Ann Oncol 6:297-299, 1995.
11. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL: Cyclin D1 protein expression in low grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86-96, 1994.
12. Vasef MA, Medeiros LJ, Koo C, McCourty A, Brynes RK: Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low grade B-cell neoplasms in bone marrow. Am J Clin Pathol 108:302-307, 1997.
13. Norton AJ, Matthew J, Pappa V, Shamash J, Love S, Rohatiner AZS, Lister TA: Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 6:249-256, 1995.
14. Velders GA, Kluin-Nelemans JC, De Boer CJ, Hermans J, Noordijk EM, Kramer MHH, Van Deijk WA, Rahder JB, Kluin PM, Van Krieken JH: Mantle-cell lymphoma: A population-based clinical study. J Clin Oncol 14:1269-1274, 1996.
15. Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A, Cavalli F: Patterns of survival in mantle cell lymphoma. Ann Onol 6:257-262, 1995.
16. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, Meerwaldt JH, Hagenbeek A, van Glabbeke M, Somers R, Bijnens L, Noordijk EM, De Wolf Peeters: Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. J Clin Oncol 13:2819-2826, 1995.
17. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM: A clinical analysis of two indolent lymphomas entities: Mantle cell lymphomas and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B cell subcategories): A Southwest Oncology Group Study. Blood 85:1075-1082, 1995.
18. Berger F, Felman P, Sonet A, Bastion Y, Bryon PA, Coiffier B: Non-follicular small B cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829-2835, 1994.
19. Pittaluga S, Bijnens L, Teodorovic I, Hagenbeek A, Meerwaldt JH, Somers R, Thomas J, Noordijk EM, De Wolf-Peeters C: Clinical analysis of 670 cases in two trials of the EORTC lymphoma cooperative group subtyped according to the REAL classification of lymphoid neoplasm: A comparison with the Working Formulation. Blood 10:4358-4367, 1996.
20. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD: Mantle cell lymphoma: A clinicopathologic study of 80 cases. Blood 89:2067-2078, 1997.
21. Majlis A, Pugh WC, Rodriguez MA, Benedict WF, Cabanillas F: Mantle cell lymphoma: Correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol 15:164-171, 1997.
22. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory, 1982, Chap. 9, p 280.
23. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, Schuuring E, Kluin PM: Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528-2536, 1995.
24. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, Braylan RC, Kjeldsberg CR: Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 83:1626-1631, 1994.
25. Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ: Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci 85:4869-4873, 1988.
26. Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA: Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma. Am J Clin Pathol 103:472-478, 1995.
27. Greer CE, Peterson SL, Kiviat NB, Manos MM: PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 95:117-124, 1991.
28. Meusers P, Engelhard M, Bartels H, Binder T, Fulle HH, Gorg K, Gunzer U, Havemann K, Kayser W, Konig E, Kuse R, Loffler H, Ludwig WD, Mainzer K, Martin H, Pralle H, Schoppe WD, Staiger HJ, Theml H, Zurborn KH, Zwingers TH, Lennert K, Brittinger G: Multi-center randomised therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis. Hematol Oncol 7:365-380, 1989.
29. Rohatiner AZS, Lister TA: New approaches to the treatment of follicular lymphoma. Br J Haematol 79:349-354, 1991.
30. Williams ME, Meeker TC, Swerlow SH: Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: Analysis with multiple breakpoint probes. Blood 78:493-499, 1991.
31. Lim LC, Segal GH, Wittwer CT: Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues. Am J Clin Pathol 104:689-695, 1995.
32. Kroger N, Hoffknecht M, Dreger P, Kruger W, Zeller W, Krull A, Stokschlader M, Bittner S, Weh HJ, Zander AR: Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy. Bone Marrow Transplant 21:55-57, 1988.
33. Haas R, Brittinger G, Meusers P, Murea S, Goldschmidt H, Wannenmacher M, Hunstein W: Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma. Leukemia 10: 1975-1979, 1996.
34. Stewart DA, Vose JM, Weisenberger DD, Anderson JR, Ruby EI, Bast MA, Bierman PJ, Kessinger A, Armitage JO: The role of high-dose therapy and autologous stem cell transplantation for mantle cell lymphoma. Ann Oncol 6:263-266, 1995.
35. Ketterer N, Salles G, Espinouse D, Dumontet C, Neidhardt-Bernard EM, Moullet I, Bouafia F, Berger F, Felman P, Coiffier B: Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma. Ann Oncol 8:701-704, 1997.